Transfusion Medicine Reviews
Volume 22, Issue 2 , Pages 117-132 , April 2008

Integrating Molecular Technologies for Red Blood Cell Typing and Compatibility Testing Into Blood Centers and Transfusion Services

References 

  1. Reid ME. Overview of molecular methods in immunohematology. Transfusion. 2007;47:10S–16S[1 Suppl]
  2. Hillyer CD. Blood banking and transfusion medicine: Basic principles and practice. Ed 2. Philadelphia: Churchill Livingstone/Elsevier; 2007;
  3. Reid ME. Applications of DNA-based assays in blood group antigen and antibody identification. Transfusion. 2003;43:1748–1757
  4. Avent ND. Large scale blood group genotyping. Transfus Clin Biol. 2007;14:10–15
  5. Flickinger C, Petrone T, Church A. Review: American Rare Donor Program. Immunohematol. 2004;20:239–243
  6. Woodfield G, Poole J, Nance ST, et al. A review of the ISBT rare blood donor program. Immunohematol. 2004;20:244–248
  7. Hashmi G, Shariff T, Zhang Y, et al. Determination of 24 minor red blood cell antigens for more than 2000 blood donors by high-throughput DNA analysis. Transfusion. 2007;47:736–747
  8. AABB . Standards for blood banks and transfusion services. Ed 24. Bethesda: AABB; 2006;
  9. Wagner F, Frohmajer A, Flegel W. RHD positive haplotypes in D negative Europeans. BMC Genet. 2001;2:10
  10. Flegel WA. How I manage donors and patients with a weak D phenotype. Curr Opin Hematol. 2006;13:476–483
  11. Polin H, Danzer M, Hofer K, et al. Effective molecular RHD typing strategy for blood donations. Transfusion. 2007;47:1350–1355
  12. Hult A, Hellberg A, Wester ES, et al. Blood group genotype analysis for the quality improvement of reagent test red blood cells. Vox Sang. 2005;88:265–270
  13. Storry JR, Olsson ML, Reid ME. Application of DNA analysis to the quality assurance of reagent red blood cells. Transfusion. 2007;47:73S–78S[1 Suppl]
  14. Olsson ML, Irshaid NM, Hosseini-Maaf B, et al. Genomic analysis of clinical samples with serologic ABO blood grouping discrepancies: Identification of 15 novel A and B subgroup alleles. Blood. 2001;98:1585–1593
  15. Reid ME. DNA analysis to find rare blood donors when antisera is not available. Vox Sang. 2002;83:91–93
  16. Rozman P, Dovc T, Gassner C. Differentiation of autologous ABO, RHD, RHCE, KEL, JK, and FY blood group genotypes by analysis of peripheral blood samples of patients who have recently received multiple transfusions. Transfusion. 2000;40:936–942
  17. Wenk RE, Chiafari PA. DNA typing of recipient blood after massive transfusion. Transfusion. 1997;37:1108–1110
  18. Reid ME, Rios M, Powell VI, et al. DNA from blood samples can be used to genotype patients who have recently received a transfusion. Transfusion. 2000;40:48–53
  19. Lee E, Hart K, Burgess G, et al. Efficacy of murine monoclonal antibodies in RBC phenotyping of DAT-positive samples. Immunohematol. 2006;22:161–165
  20. Judd WJ, Moulds M, Schlanser G. Reactivity of FDA-approved anti-D reagents with partial D red blood cells. Immunohematol. 2005;21:146–148
  21. Price CL, Boyd JH, Watkins AR, et al. Mailing of a sickle cell disease educational packet increases blood donors within an African American community. Transfusion. 2006;46:1388–1393
  22. Smith LA, Oyeku SO, Homer C, et al. Sickle cell disease: a question of equity and quality. Pediatrics. 2006;117:1763–1770
  23. Josephson CD, Su LL, Hillyer KL, et al. Transfusion in the patient with sickle cell disease: A critical review of the literature and transfusion guidelines. Transfus Med Rev. 2007;21:118–133
  24. Aygun B, Padmanabhan S, Paley C, et al. Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions. Transfusion. 2002;42:37–43
  25. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle-cell anemia and transfusion of racially unmatched blood. N Engl J Med. 1990;322:1617–1621
  26. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle-cell disease. Blood. 1990;76:1431–1437
  27. Luban NL. Variability in rates of alloimmunization in different groups of children with sickle cell disease: Effect of ethnic background. Am J Pediatr Hematol Oncol. 1989;11:314–319
  28. Hendrickson JE, Chadwick TE, Roback JD, et al. Inflammation enhances consumption and presentation of transfused RBC antigens by dendritic cells. Blood. 2007;110:2736–2743
  29. Yu J, Heck S, Yazdanbakhsh K. Prevention of red cell alloimmunization by CD25 regulatory T cells in mouse models. Am J Hematol. 2007;82:691–696
  30. Hendrickson JE, Desmarets M, Deshpande SS, et al. Recipient inflammation affects the frequency and magnitude of immunization to transfused red blood cells. Transfusion. 2006;46:1526–1536
  31. Okpala I. The intriguing contribution of white blood cells to sickle cell disease—A red cell disorder. Blood Rev. 2004;18:65–73
  32. Afenyi-Annan A, Bandarenko N. Transfusion practices for patients with sickle cell disease at a major academic center. Immunohematol. 2007;22:103–107
  33. Tahhan HR, Holbrook CT, Braddy LR, et al. Antigen-matched donor blood in the transfusion management of patients with sickle-cell disease. Transfusion. 1994;34:562–569
  34. Castilho L, Rios M, Bianco C, et al. DNA-based typing of blood groups for the management of multiply-transfused sickle cell disease patients. Transfusion. 2002;42:232–238
  35. Rund D, Rachmilewitz E. Medical progress: Beta-thalassemia. N Engl J Med. 2005;353:1135–1146
  36. Singer ST, Wu V, Mignacca R, et al. Alloimmunization and erythrocyte autoimmunization in transfusion-dependent thalassemia patients of predominantly Asian descent. Blood. 2000;96:3369–3373
  37. Ho HK, Ha SY, Lam CK, et al. Alloimmunization in Hong Kong southern Chinese transfusion-dependent thalassemia patients. Blood. 2001;97:3999–4000
  38. Castilho L, Rios M, Pellegrino J, et al. Blood group genotyping facilitates transfusion of beta-thalassemia patients. J Clin Lab Anal. 2002;16:216–220
  39. Shirey RS, Boyd JS, Parwani AV, et al. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: An algorithm for transfusion management. Transfusion. 2002;42:1435–1441
  40. Garratty G, Petz LD. Approaches to selecting blood for transfusion to patients with autoimmune hemolytic anemia. Transfusion. 2002;42:1390–1392
  41. Lau FY, Wong R, Chan NPH, et al. Provision of phenotype-matched blood units: No need for pre-transfusion antibody screening. Haematologica. 2001;86:742–748
  42. Domen RE. Policies and procedures related to weak D phenotype testing and Rh immune globulin administration—Results from supplementary questions to the Comprehensive Transfusion Medicine Survey of the College of American Pathologists. Arch Pathol Lab Med. 2000;124:1118–1121
  43. Judd WJ. Practice guidelines for prenatal and perinatal immunohematology, revisited. Transfusion. 2001;41:1445–1452
  44. Nelson M, Eagle C, Langshaw M, et al. Genotyping fetal DNA by non-invasive means: Extraction from maternal plasma. Vox Sang. 2001;80:112–116
  45. Bellissimo DB. Practice guidelines and proficiency testing for molecular assays. Transfusion. 2007;47:79S–84S[1 Suppl]
  46. Lomas-Francis C, Reid ME. A summary of ISBT/ICSH international workshops and proficiency tests for molecular blood group genotyping. Transfusion. 2007;47:95S–97S[1 Suppl]
  47. Mathew SM, King MR, Glynn SA, et al. Opinions about donating blood among those who never gave and those who stopped: A focus group assessment. Transfusion. 2007;47:729–735

PII: S0887-7963(07)00111-3

doi: 10.1016/j.tmrv.2007.12.002

Transfusion Medicine Reviews
Volume 22, Issue 2 , Pages 117-132 , April 2008

Article Tools

* Image Usage & Resolution